Selective Binding of Bladder Muscarinic Receptors in Relation to the Pharmacokinetics of a Novel Antimuscarinic Agent, Imidafenacin, to Treat Overactive Bladder

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Marie‐Laure Ancelin, Sylvaine Artéro, Florence Portet et al. · BMJ · 2006 · 575 citations · Full text

Medicine, Geriatric Medicine, Psychiatry +15

Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

P Wang, G R Luthin, Michael R. Ruggieri · Journal of Pharmacology and Experimental Therapeutics · 1995 · 275 citations

Life Sciences, Biochemistry, Pharmacology +17

Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride

Ira R. Katz, Laura P. Sands, Warren B. Bilker et al. · Journal of the American Geriatrics Society · 1998 · 258 citations

Medicine, Pharmacology, Pharmacotherapy +13

Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.

Shizuo Yamada, Henry I. Yamamura, William R. Roeske · Journal of Pharmacology and Experimental Therapeutics · 1980 · 130 citations

Medicine, Cardiology, Pharmacology +14

A randomized, double‐blind, placebo‐ and propiverine‐controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

Yukio Homma, Osamu Yamaguchi · International Journal of Urology · 2009 · 89 citations

Medicine, Pharmacology, Pharmacotherapy +11